Skip to content

Total at other companies

Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$664.17M-33.2%
First BanCorp logo
First BanCorpFBP
$5.02B+4.9%
Pitney Bowes logo
Pitney BowesPBI
$1.9M-54.6%
A10 Networks logo
A10 NetworksATEN
$194.03M+223%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$86.7M-58.6%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$718.48M

Other financials

Income statement

See full
Revenue$159.5M+22.6%
Net income$41.7M-1.1%
EPS (diluted)$2.39-8.1%

Balance sheet

See full
Cash & equivalents$983.1M+314%
Total debt$154.1M+56.2%
Total equity$1.7B+32.9%
Total assets$13.0B+31.3%

Cash flow

See full
Operating cash flow$30.9M-18.1%
CapEx$4.3M+296%
Free cash flow$26.6M-27.3%

Valuation

See full
Market cap$3.24B+20.7%

Profitability

See full
Net margin30.6%+0.7pp
FCF margin31%-2.0pp

Returns & leverage

See full
Return on equity12.1%-0.9pp
Debt / equity0.1×0.0×

Where this comes from

Reported directly by Park National in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: Park National’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Park National's total.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Park National's total?
Park National (PRK) reported total of $1.28B in Q1 2026.
How has Park National's total changed year-over-year?
Park National's total increased by 27.1% year-over-year, from $1B to $1.28B.
What is the long-term trend for Park National's total?
Over 5 years (2020 to 2025), Park National's total has grown at a -6.3% compound annual growth rate (CAGR), from $1.01B to $729.61M.